Suchergebnisse - "Hildebrandt, Martin"

PubPharm (82)

11

Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy : A Randomized Phase II Clinical Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Multhoff, G. | Seier, S. | Stangl, S. | +22

12

COVID-19 from the Perspective of Haematology and Haemostaseology

enthalten in: Deutsche medizinische Wochenschrift (1946) | 2020

von Spiekermann, K. | Subklewe, M. | Hildebrandt, M. | +2

13

Horses for courses : an approach to the qualification of clinical trial sites and investigators in ATMPs

enthalten in: Drug discovery today | 2020

von Hildebrandt, M.

14

Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control : a case study

enthalten in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al | 2019

von Kokowski, K. | Stangl, S. | Seier, S. | +3

15

Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study

enthalten in: Strahlentherapie und Onkologie | 2019

von Kokowski, K. | Stangl, S. | Seier, S. | +3

16

Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study

enthalten in: Strahlentherapie und Onkologie | 2019

von Kokowski, K. | Stangl, S. | Seier, S. | +3

17

Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study

enthalten in: Strahlentherapie und Onkologie | 2019

von Kokowski, K. | Stangl, S. | Seier, S. | +3

18

Targeted in-vitro-stimulation reveals highly proliferative multi-virus-specific human central memory T cells as candidates for prophylactic T cell therapy

enthalten in: PloS one | 2019

von Faist, B. | Schlott, F. | Stemberger, C. | +11

19

Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies-the German Cancer Consortium approach

enthalten in: Cancer immunology, immunotherapy : CII | 2018

von Krackhardt, A. | Anliker, B. | Hildebrandt, M. | +9

20

Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies—the German Cancer Consortium approach

enthalten in: Cancer immunology immunotherapy | 2018

von Krackhardt, A. | Anliker, B. | Hildebrandt, M. | +9